Showing 1721-1730 of 9125 results for "".
Patient Reminders
https://practicaldermatology.com/topics/practice-management/patient-reminders/19497/Painted Faces
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2019/painted-faces/19706/Amy Forman Taub, MD seeks to determine where the visual arts and medical aesthetics overlap and to identify a standard for beauty.Comorbidities in Vitiligo
https://practicaldermatology.com/issues/august-2025/comorbidities-in-vitiligo/36702/Vitiligo is a chronic, acquired pigmentary disorder characterized by the progressive loss of function or destruction of melanocytes in the skin, hair follicles, and mucous membranes. In this piece, Dr. Brad Glick and colleagues explore comorbidities in vitiligo.A Promising Pipeline
https://practicaldermatology.com/conferences/maui-derm-2022/a-promising-pipeline/20051/Joel L. Cohen, MD says he's excited about a number of devices he's currently investigating for a wide-variety of medical and aesthetic dermatologic treatments. From body contouring to acne to hair removal, Dr. Cohen shares insights on advancing technologies for several indications.Reduce Lawsuit Risks and Minimize Tax Liabilities of Owning Real Estate
https://practicaldermatology.com/topics/practice-management/reduce-lawsuit-risks-and-minimize-tax-liabilities-of-owning-real-estate/21044/Tips for how to protect yourself from real-estate-related lawsuits.Building for Tomorrow
https://practicaldermatology.com/topics/practice-management/building-for-tomorrow/23291/Tips for re-launching your practice post-COVID-19.The Excoriated and Bleeding Edge: Updates in Eczema for the Clinician
https://practicaldermatology.com/topics/general-topics/the-excoriated-and-bleeding-edge-updates-in-eczema-for-the-clinician/21469/Atopic dermatitis continues to present treatment challenges, but a steady juggling of four main components—moisturization, antibiotics, anti-inflammatory, and antipruritics— help to maximize control of the disease.A Closer Look at Skyrizi
https://practicaldermatology.com/columns/clinical-focus-1/a-closer-look-at-skyrizi/23016/The newest IL-23 blocker for psoriasis may prove to be a blockbuster, according to analysts.First, Do No Harm
https://practicaldermatology.com/topics/psoriasis/first-do-no-harm/20343/Weighing the data on Cimzia during pregnancy and lactation.The Acne Therapy Pipeline
https://practicaldermatology.com/topics/acne-rosacea/the-acne-therapy-pipeline/19724/From new agents to improved formulations, Lawrence Eichenfield, MD breaks down the latest advances in acne therapy.